Lowe Brockenbrough & CO Inc Eli Lilly & CO Transaction History

Lowe Brockenbrough & CO Inc

$1.49 Billion
Q2 2024

A detailed history of Lowe Brockenbrough & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Lowe Brockenbrough & CO Inc holds 6,830 shares of LLY stock, worth $6.09 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

6,830

Previous 7,145 4.41%

Holding current value

$6.09 Million

Previous $5.56 Million 11.25%

% of portfolio

0.41%

Previous 0.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $228,334 - $286,347	-315 Reduced 4.41%	6,830 $6.18 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $241,025 - $322,457	407 Added 6.04%	7,145 $5.56 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $25,209 - $29,718	-48 Reduced 0.71%	6,738 $3.93 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $108,675 - $149,825	-250 Reduced 3.55%	6,786 $3.64 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $49,805 - $66,595	-142 Reduced 1.98%	7,036 $3.3 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $58,398 - $68,586	188 Added 2.69%	7,178 $2.47 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $64,310 - $74,934	-200 Reduced 2.78%	6,990 $2.56 Million
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $88,944 - $101,361	-300 Reduced 4.01%	7,190 $2.33 Million
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $46,826 - $54,981	-168 Reduced 2.19%	7,490 $2.43 Million
Q1 2022 May 04, 2022	SELL	$234.69 - $291.66 $70,407 - $87,498	-300 Reduced 3.77%	7,658 $2.19 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $220,517 - $285,470	-1,342 Reduced 14.43%	7,958 $1.49 Million
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $15,655 - $20,715	-120 Reduced 1.27%	9,300 $1.57 Million
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $7,311 - $8,456	50 Added 0.53%	9,420 $1.39 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $6,820 - $8,209	-50 Reduced 0.53%	9,370 $1.54 Million
Q1 2020 May 21, 2020	SELL	$119.05 - $147.35 $105,835 - $130,994	-889 Reduced 8.62%	9,420 $1.31 Million
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $1,496 - $1,854	14 Added 0.14%	10,309 $1.36 Million
Q3 2019 Nov 21, 2019	BUY	$106.79 - $116.16 $32,037 - $34,848	300 Added 3.0%	10,295 $1.15 Million
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $52,950 - $59,320	-500 Reduced 4.76%	9,995 $1.16 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $96,249 - $120,294	-1,121 Reduced 9.65%	10,495 $1.13 Million
Q1 2018 Apr 30, 2018	BUY	$74.21 - $87.6 $31,242 - $36,879	421 Added 3.76%	11,616 $899,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $862,798 - $957,620	11,195	11,195 $958,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.

Account

Lowe Brockenbrough & CO Inc Eli Lilly & CO Transaction History